The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trial

BACKGROUND: The OPTION trial results showed that premenopausal women with early stage breast cancer (EBC) receiving chemotherapy benefited from ovarian function protection with goserelin. The impact of treatments on patient reported Quality of Life (QoL) were also examined. PATIENTS AND METHODS: 227...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast
Main Authors: R, Leonard, A, Yellowlees, J, Mansi, L, Fallowfield, V, Jenkins
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7303950/
https://ncbi.nlm.nih.gov/pubmed/32505861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2020.05.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados